Better survival seen in NSCLC patients who take beta blockers

01/15/2013 | News-Medical.Net

A new study has found beta blocker treatment was associated with better survival without distant metastases, improved disease-free survival and better overall survival among patients with non-small-cell lung cancer being treated with definitive radiotherapy compared with those who did not take beta blockers. The research appears in the Annals of Oncology.

View Full Article in:

News-Medical.Net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR